Aclarion Inc (ACON) - Net Assets
Based on the latest financial reports, Aclarion Inc (ACON) has net assets worth $12.50 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.20 Million) and total liabilities ($699.75K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Aclarion Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $12.50 Million |
| % of Total Assets | 94.7% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Aclarion Inc - Net Assets Trend (2019–2024)
This chart illustrates how Aclarion Inc's net assets have evolved over time, based on quarterly financial data. Also explore ACON asset base for the complete picture of this company's asset base.
Annual Net Assets for Aclarion Inc (2019–2024)
The table below shows the annual net assets of Aclarion Inc from 2019 to 2024. For live valuation and market cap data, see Aclarion Inc stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $970.06K | +233.25% |
| 2023-12-31 | $-728.00K | -132.70% |
| 2022-12-31 | $2.23 Million | +138.85% |
| 2021-12-31 | $-5.73 Million | +19.12% |
| 2020-12-31 | $-7.08 Million | -316.21% |
| 2019-12-31 | $-1.70 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Aclarion Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3081908300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $52.23 Million | 5384.46% |
| Total Equity | $970.06K | 100.00% |
Aclarion Inc Competitors by Market Cap
The table below lists competitors of Aclarion Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kulthorn Kirby Public Company Limited
BK:KKC
|
$1.87 Million |
|
RIVER TECH EO -005
F:9YQ
|
$1.87 Million |
|
Painreform Ltd
NASDAQ:PRFX
|
$1.87 Million |
|
GRAPHANO ENERGY LTD
F:97G0
|
$1.88 Million |
|
Ucommune International Ltd
NASDAQ:UK
|
$1.86 Million |
|
Himalaya Energi Perkasa Tbk PT
JK:HADE
|
$1.86 Million |
|
Black Hawk Acquisition Corporation Rights
NASDAQ:BKHAR
|
$1.86 Million |
|
TCI Finance Limited
NSE:TCIFINANCE
|
$1.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aclarion Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -727,995 to 970,057, a change of 1,698,052.
- Net loss of 6,992,927 reduced equity.
- Dividend payments of 59,675 reduced retained earnings.
- New share issuances of 6,573,075 increased equity.
- Other factors increased equity by 2,177,579.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-6.99 Million | -720.88% |
| Dividends Paid | $59.67K | -6.15% |
| Share Issuances | $6.57 Million | +677.6% |
| Other Changes | $2.18 Million | +224.48% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Aclarion Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-34299.40 | $3.21 | x |
| 2020-12-31 | $-142756.99 | $3.21 | x |
| 2021-12-31 | $-115463.91 | $3.21 | x |
| 2022-12-31 | $52760.32 | $3.21 | x |
| 2023-12-31 | $-11825.78 | $3.21 | x |
| 2024-12-31 | $1028.87 | $3.21 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aclarion Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -720.88%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -15293.78%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 2.19x
- Recent ROE (-720.88%) is below the historical average (-173.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -14943.15% | 0.02x | 0.00x | $-3.85 Million |
| 2020 | 0.00% | -9527.35% | 0.04x | 0.00x | $-3.93 Million |
| 2021 | 0.00% | -8210.53% | 0.03x | 0.00x | $-4.38 Million |
| 2022 | -317.55% | -11694.45% | 0.02x | 1.31x | $-7.29 Million |
| 2023 | 0.00% | -6513.41% | 0.03x | 0.00x | $-4.84 Million |
| 2024 | -720.88% | -15293.78% | 0.02x | 2.19x | $-7.09 Million |
Industry Comparison
This section compares Aclarion Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $319,495,544
- Average return on equity (ROE) among peers: -5.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aclarion Inc (ACON) | $12.50 Million | 0.00% | 0.06x | $1.87 Million |
| American Well Corp (AMWL) | $374.94 Million | -23.25% | 0.33x | $119.89 Million |
| Heartbeam Inc (BEAT) | $134.93 Million | -14.72% | 0.16x | $47.14 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $-1.01 Million | 0.00% | 0.00x | $6.51 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $800.46 Million | 6.22% | 5.89x | $10.63 Billion |
| Carlsmed, Inc. Common Stock (CARL) | $-46.13 Million | 0.00% | 0.00x | $266.41 Million |
| CareCloud, Inc. (CCLD) | $101.25 Million | -8.70% | 0.36x | $96.88 Million |
| Certara Inc (CERT) | $1.06 Billion | -1.14% | 0.49x | $833.89 Million |
| CareMax Inc (CMAX) | $619.55 Million | -6.10% | 0.89x | $381.50 |
| Claritev Corporation (CTEV) | $-167.18 Million | 0.00% | 0.00x | $369.43 Million |
About Aclarion Inc
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom softwa… Read more